Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ranchoux, E. Henault, S. J. Dumas, S. Chantepie, D. Montani, B. Girerd, A. Blanchet de la Sablière, E. Fadel, P. Dartevelle, D. Papy-Garcia, M. Humbert, F. Perros, P. Albanese, S. Cohen-Kaminsky (Le Plessis Robinson, Le Kremlin Bicêtre, Créteil, France). Lung heparan and chondroitine sulfate imbalance and functional changes in pulmonary hypertension. Eur Respir J 2014; 44: Suppl. 58, 304

Member's Comments

No comment yet.

Related content which might interest you: Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Inflammasome ASC-knock out attenuates the development of pulmonary hypertension caused by chronic alveolar hypoxia Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Th17 inflammation and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Endothelial microparticles and progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary hemodynamics and lung function in patients with COPD and DPLD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Molecular study of genetic modifiers in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Female pulmonary arterial hypertension is associated with decreased microRNA96 expression Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Lung capillary blood volume and membrane diffusion in PH Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Smad1 deficiency and female gender contribute to the development of pulmonary hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 LATE-BREAKING ABSTRACT: The bromodomain-containing protein 4: the epigenetic origin of the oncogenic signature in pulmonary hypertension Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Impact of sepsis in respiratory mechanics of pulmonary arterial hypertension rat model. Preliminary results Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 The flavonoid quercetin reverses monocrotaline-induced pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Skeletal muscle impairment and proteomic profil in human pulmonary arterial hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014